DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis

[at noodls] – Gelclair Launch Expected to Provide Additional Commercial Revenue for DARA in 2013 RALEIGH, NC and LUGANO, SWITZERLAND — (Marketwired) — 04/22/13 — DARA BioSciences, Inc. (NASDAQ: DARA), a specialty … more

View todays social media effects on DARA

View the latest stocks trending across Twitter. Click to view dashboard

See who DARA is hiring next, click here to view